Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 5, 2013, Pages 535-542

  Nichols, Nicole L ^a   Gowing, Genevieve ^b   Satriotomo, Irawan ^a   Nashold, Lisa J ^a   Dale, Erica A ^a   Suzuki, Masatoshi ^a   Avalos, Pablo ^b   Mulcrone, Patrick L ^a   McHugh, Jacalyn ^b   Svendsen, Clive N ^b   Mitchell, Gordon S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Growth factors; Motor neuron; Respiratory plasticity; Spinal cord; Ventilatory control

Indexed keywords

ACUTE INTERMITTENT HYPOXIA; AMYOTROPHIC LATERAL SCLEROSIS; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; INTERMITTENT HYPOXIA; MALE; NEURAL STEM CELL; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANOXIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INSPIRATORY CAPACITY; MALE; MOTOR NEURONS; PHRENIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY; STEM CELL TRANSPLANTATION; SUPEROXIDE DISMUTASE;

EID: 84875175026     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201206-1072OC     Document Type: Article

References (51)

1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet 2011; 377:942-955.
2. Zinman L, Cudkowicz M. Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol 2011;10:481-490.
3. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124:110-118.
4. Ilzecka J, Stelmasiak Z, Balicka G. Respiratory function in amyotrophic lateral sclerosis. Neurol Sci 2003;24:288-289.
5. Singh D, Verma R, Garg RK, Singh MK, Shukla R, Verma SK. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis. J Neurol Sci 2011; 306:76-81.
6. Bourke SC, Shaw PJ, Gibson GJ. Respiratory function vs. sleepdisordered breathing as predictors of QOL in ALS. Neurology 2001; 57:2040-2044.
7. Lechtzin N, Rothstein J, Clawson L, Diette G, Wiener CM. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotroph Lateral Scler 2002;3:5-13.
8. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009; 187:761-772.
9. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65:S3-S9.
10. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:616-630.
11. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008;11:251-253.
12. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008;11:1294-1301.
13. Henriques A, Pitzer C, Schneider A. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci 2010;4:32.
14. Gould TW, Oppenheim RW. Motor neuron trophic factors: therapeutic use in ALS? Brain Res Brain Res Rev 2011;67:1-39.
15. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA; North America ALS/IGF-1 Study Group. Effect of recombinant human insulin-like growth factor-I on progression of ALS: a placebo-controlled study. Neurology 1997;49:1621-1630.
16. Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, Silani V, Vos PE, Wokke JH, Dobbins T; European ALS/IGF-I Study Group. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Neurology 1998;51:583-586.
17. Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:201-206.
18. Cedarbaum JM, Stambler N; BDNF Study Group. Disease status and use of ventilatory support by ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:19-22.
19. Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, Naumann M. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:100-103.
20. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
21. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, Mitchell GS. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 2004;7:48-55.
22. Mitchell GS. Respiratory plasticity following intermittent hypoxia: a guide for novel therapeutic approaches to ventilatory control disorders. In: Gaultier C, editor. Genetic basis for respiratory control disorders. New York: Springer; 2007. pp. 291-306.
23. Klein SM, Behrstock S, McHugh J, Hoffman K, Wallace K, Suzuki M, Aegischer P, Svendsen CN. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005;16:509-521.
24. Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2007;2:e689.
25. Satriotomo I, Nashold LJ, Svendsen CN, Mitchell GS. Enhancement of BDNF and serotonin terminal density in phrenic and hypoglossal motor nuclei in a rat model of amyotrophic lateral sclerosis (ALS) [abstract]. FASEB J 2006;20:A1212.
26. Gowing G, Nichols NL, Suzuki M, McHugh J, Hayes A, Mulcrone P, Mitchell GS, Svendsen CN. Targeting of human neural progenitor cells expressing GDNF to the cervical spinal cord of a rat model of ALS [abstract]. Soc Neurosci Abstr 2010;753.11.
27. Nichols NL, Gowing G, Suzuki M, Svendsen CN, Mitchell GS. GDNF secreting stem cell implants strengthen phrenic motor output in SOD1G93A rats [abstract]. Soc Neurosci Abstr 2010;753.10.
28. Lovett-Barr MR, Satriotomo I, Muir G, Wilkerson JER, Hoffman MS, Vinit S, Mitchell GS. Repetitive intermittent hypoxia induces respiratory and somatic motor recovery following chronic cervical spinal injury. J Neurosci 2012;32:3591-3600.
29. Hoffman MS, Mitchell GS. Spinal 5-HT receptor activation induces long-lasting phrenic motor facilitation. J Physiol 2011;589:1397-1407.
30. Mantilla CB, Zhan WZ, Sieck GC. Retrograde labeling of phrenic motoneurons by intrapleural injection. J Neurosci Methods 2009;182: 244-249.
31. Boulenguez P, Gestreau C, Vinit S, Stamegna JC, Kastner A, Gauthier P. Specific and artifactual labeling in the rat spinal cord and medulla after injection of monosynaptic retrograde tracers into the diaphragm. Neurosci Lett 2007;417:206-211.
32. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnet SB. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol 1997;148:135-146.
33. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998;85:141-152.
34. Déglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 2000;11: 179-190.
35. Tankersley CG, Haenggeli C, Rothstein JD. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. J Appl Physiol 2007; 102:926-932.
36. Llado J, Haenggeli C, Pardo A, Wong V, Benson L, Coccia C, Rothstein JD, Shefner JM, Maragakis NJ. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis 2005;21:110-118.
37. Golder FJ, Mitchell GS. Spinal synaptic enhancement with acute intermittent hypoxia improves respiratory function after chronic cervical spinal cord injury. J Neurosci 2005;25:2925-2932.
38. Dale-Nagle EA, Satriotomo I, Mitchell GS. Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling. J Neurosci 2011;31:7682-7690.
39. Dale EA, Satriotomo I, Mitchell G. Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci 2012;32:5973-5983.
40. Satriotomo I, Dale EA, Dahlberg JM, Mitchell GS. Repetitive acute intermittent hypoxia increases expression of proteins associated with plasticity in the phrenic motor nucleus. Exp Neurol 2012;237:103-115.
41. Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L. Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS ONE 2012;7: e39946.
42. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci 2000;20:5001-5011.
43. Kanning KC, Kaplan A, Henderson CE. Motor neuron diversity in development and disease. Annu Rev Neurosci 2010;33:409-440.
44. Jessell TM. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet 2000;1:20-29.
45. Liu JP, Laufer E, Jessell TM. Assigning the positional identity of spinal motor neurons: rostrocaudal patterning of Hox-c protein expression by FGFs, Gdf11 and retinoids. Neuron 2001;32:997-1012.
46. Alaynick WA, Jessell TM, Pfaff SL. Snapshot: spinal cord development. Cell 2011;146:178.
47. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 2000; 164:215-226.
48. Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 2011;6:e25968.
49. Trumbower RD, Jayaraman A, Mitchell GS, Rymer WZ. Exposure to acute intermittent hypoxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabil Neural Repair 2012;26:163-172.
50. Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL. Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 2011;8:172-176.
51. Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Stem cell technology for the study and treatment of motor neuron diseases. Regen Med 2011;6:201-213.